Date

Monday, 23 September 2024, 14:00 (CEST) - 16:30 (CEST)

Location

Online
European Medicines Agency, Amsterdam, the Netherlands

Event summary

EMA is initiating a new pilot programme for the expert panels to support manufacturers manufacturing and notified bodies certifying orphan medical devices with the challenges linked to generating clinical evidence for these devices in the premarket phase (see Medical devices). 

The expert panels can offer advice on the orphan device’s status, the intended clinical development strategies, proposed clinical investigations, or on the data required for the clinical evaluation during an ongoing conformity assessment. This programme is being launched as a pilot to help implement the processes outlined in the MDCG 2024-10 document on clinical evaluation of orphan medical devices.

Starting from 2 August 2024, EMA will begin accepting letters of interest from manufacturers and notified bodies that would like to be considered for this pilot. Therefore, EMA, in collaboration with representatives from the European Commission, the Medical Device Coordination Group (MDCG) and the expert panels, is planning a joint information session that will cover the following topics: 

  • Introduction of the new definition and criteria for the orphan status for medical devices in the EU;
  • Strategies for manufacturers to overcome the challenges in generating clinical evidence for orphan devices considering the limitations in pre-market clinical data and how the post-market phase can be utilised to mitigate such limitations;
  • Overview of the new pilot programme and how to apply for scientific support from the expert panels; 
  • Demo of the submission portal.

Video recording

Documents

Submit questions

Attendees can submit questions until 10 October 2024 (COB):

A Q&A document will be published after that date.

You can also use the QR code below to access the platform.

QR code submit questions medical devices workshop

Share this page